September 4, 2026
Lockheed Martin Got a 7-Year Missile Order.
When the Pentagon commits to tripling PAC-3 and quadrupling THAAD output against an active Gulf conflict
On Monday, August 31, the Department of Defense announced something genuinely significant: seven-year framework agreements with Lockheed Martin and General Dynamics Ordnance and Tactical Systems to triple PAC-3 MSE interceptor production capacity and quadruple THAAD output. The agreements cover motor cases, seeker housings, midsections, and shroud deployment systems, with guaranteed minimum annual quantities and accelerated delivery schedules.
Jon Najarian’s Shocking “Beyond SpaceX” Prediction
For 16 years, Jon Najarian was a fixture on CNBC’s Fast Money – known as the man in the red beret.
He called Apple in 2010, Tesla in 2014, and Palantir in 2020. Now that the SpaceX IPO is in the books, he’s making what he believes could be his most important call of the decade.
A shocking prediction about what comes “Beyond SpaceX.”
Shares of both companies barely moved, slipping less than half a percent apiece. That is the story.
Why This Stock Now
The indifference is not irrational. Big capability multipliers without attached contract values tend to get filed as confirmation of an existing growth story rather than treated as a fresh catalyst. But the backdrop here is different from a peacetime procurement announcement, and the market may be underweighting it.
The United States reportedly began with approximately 2,330 Patriot interceptors before expending around 65 percent during the Iran conflict, leaving an estimated 759 to 827 missiles available by late July 2026. THAAD reserves also reportedly declined from approximately 452 interceptors before the war to between 234 and 278. These are not projections. They are the inventory reality the August 31 agreements are designed to address.
The Business
Lockheed Martin is the prime contractor for both the PAC-3 MSE interceptor and the THAAD system. That matters here because GD-OTS supplies critical subcomponents, but Lockheed captures the system-level economics. Every motor case General Dynamics produces feeds a missile Lockheed builds and books revenue on.
In late July 2026, the U.S. government awarded Lockheed Martin a seven-year undefinitized contract action modification worth up to $53.86 billion for PAC-3 Missile Segment Enhancement interceptors, expanding a multiyear procurement ceiling now totaling about $58.62 billion for fiscal years 2026 to 2032. The August 31 component-level agreements layer onto that structure, providing the subcontractor base with the same long-term demand signal Lockheed itself received weeks earlier.
SpaceX was the biggest IPO in history. Yet there’s some investors who are losing money and some that are not. Here’s why.
SpaceX just taught investors a brutal lesson.
Everyone who bought shares on IPO day is losing money after the stock fell 40% from its high.
Meanwhile, Pre-IPO investors are still sitting on gains.
The real money is made BEFORE the stock starts trading.
Anthropic and OpenAI are next. Both filed with the SEC in June. That’s why I’m claiming my pre-IPO stake right now.
I’d like to send you important details inside this special report:
Inside the Anthropic and OpenAI Pre-IPOs
Revenue topped $20.06 billion, up about 11% compared with the year-ago quarter, while the company raised its 2026 sales and EPS guidance to $79.75 to $81.75 billion and $29.95 to $30.65 per share.
Why Wall Street Is Paying Attention
The Army’s PAC-3 ceiling totals about $58.62 billion for fiscal years 2026 to 2032, which if divided evenly would amount to roughly $8.37 billion per year. Set against a recent share price near $545, that contract ceiling alone represents a large portion of Lockheed’s market value, spread across a program where the company has no credible competitor at scale.
According to 21 analysts polled by S&P Global, Lockheed Martin stock has a consensus rating of Hold and an average price target of $632.95. The all-time high closing price was $672.30 on March 2, 2026. The stock has fallen about 19% from that peak while the contract portfolio has grown, not shrunk.
The tension between a growing contract portfolio and a declining share price is not unique to Lockheed. Across the broader defense sector, the same question keeps surfacing: how much of the procurement surge is already baked into valuations? an analysis of whether defense stock multiples have already priced in the $1.5 trillion spending tailwind examines that valuation problem for RTX, LMT, and NOC — and the answer is more nuanced than the consensus Hold ratings suggest.
What’s Driving the Opportunity
The production acceleration responds to a sharp depletion of U.S. air defense inventory driven by sustained demand from ongoing operations and active theaters in the Middle East alongside support for Ukraine. The current conflict is drawing heavily on Patriot stocks across multiple theaters simultaneously, including defending U.S. forces and partners and protecting regional civilian and energy infrastructure.
Even at 2,000 missiles annually, rebuilding inventories and meeting allied demand would absorb years of production, because new output must serve American forces, partners, European allies, Ukraine, and other Patriot operators, all competing for the same supply chain. Lockheed controls that supply chain’s exit point.
European demand is a meaningful variable in that supply competition, and it has not softened despite recent sector volatility. When a German naval program cancellation rattled European defense stocks in late June, some investors questioned whether the continent’s procurement commitments were durable — why European defense spending math remained intact after its worst week in months makes the case that the decade-long procurement cycle is still very much in place, which matters directly for how much of Lockheed’s output Europe will absorb.
Tesla Tumbles as Musk Shifts Gears to AI
Tesla’s stock has plummeted 50%…
With top executives offloading shares.
Meanwhile, Elon Musk is channeling his energy into xAI, a rapidly growing AI venture outpacing competitors.
We’ve identified a “backdoor” investment opportunity accessible through your brokerage account.
Lockheed projects 2026 free cash flow of $7.0 to $7.2 billion, supporting a business that is simultaneously ramping capacity and compounding backlog. Plans call for $8 to $9 billion in munitions investment by 2030.
What Could Go Wrong
The bear case deserves a clear hearing. Framework agreements are not booked revenue. The agreements are designed to support multiyear procurement contracts with guaranteed minimum annual procurement quantities, subject to annual appropriations. Congress controls the funding spigot, and a political shift could delay definitization.
Production ramps also take time. Lockheed delivered a record 620 PAC-3 MSE missiles in 2025. Getting to 2,000 annually requires years of facility investment, workforce growth, and supply chain deepening, and none of that is linear. Execution risk is real.
Valuation is not obviously stretched but it is not obviously cheap either. Lockheed trades at a discount to some faster-growing aerospace and defense peers, and a discount usually reflects something, here it reflects a slower near-term revenue growth rate than faster-moving peers.
The Bottom Line
Lockheed Martin is the only company that builds PAC-3 MSE interceptors and assembles the THAAD interceptor at scale, into a conflict environment that has burned through a large share of U.S. Patriot stocks in roughly five months. The Defense Department just committed to seven years of accelerated component procurement to refill that magazine. The stock sat still. That gap between strategic urgency and price inaction is the case for LMT today: a prime contractor with unmatched program position, a roughly $58.62 billion PAC-3 contract ceiling through 2032, and a share price that has yet to reflect what sustained multi-theater depletion actually means for the order book.
